The Lipid Active Pharmaceutical Ingredient Market is witnessing robust expansion, driven by increasing demand for precision therapeutics, advanced drug delivery systems, and lipid-based biologics. Valued at US$ 3,345.56 million in 2024, the market is projected to grow at a CAGR of 6.8% from 2025 to 2032. The growing focus on lipid-based APIs stems from their critical role in enhancing...